Display Settings:

Format

Send to:

Choose Destination
    Hered Cancer Clin Pract. 2006 Sep 15;4(4):193-6.

    BRCA1 4153delA founder mutation in Russian ovarian cancer patients.

    Source

    NN Petrov Institute of Oncology, St, Petersburg, Russia; Medical Academy of Postgraduate Studies, St, Petersburg, Russia. evgeny@imyanitov.spb.ru.

    Abstract

    ABSTRACT: The BRCA1 4153delA allele is frequently referred to as the Russian founder mutation, as it was initially detected in several cancer families from Moscow. Our earlier studies have demonstrated 1% occurrence of BRCA1 4153delA heterozygosity in familial and/or early-onset and/or bilateral Russian breast cancer (BC) patients. Since literature data suggest that the 4153delA variant is more associated with ovarian cancer (OC) than with BC, we expected to reveal a highly elevated frequency of this genotype in Russian ovarian cancer series. However, real-time allele-specific PCR genotyping has detected only two BRCA1 4153delA carriers out of 177 unselected OC patients (1.1%). Both these carriers were early-onset and had serous carcinomas of grade 3. Thus, our study supports neither the Russian origin of BRCA1 4153delA mutation, nor its selectivity towards ovarian versus breast cancer predisposition.

    PMID:
    20223023
    [PubMed - in process]
    PMCID: PMC2837308
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk